ID24358A - Pengobatan atau propilaksis dari kanker prostatik dan hiperplasia prostatik benign dengan modulator selektif reseptor estrogen - Google Patents
Pengobatan atau propilaksis dari kanker prostatik dan hiperplasia prostatik benign dengan modulator selektif reseptor estrogenInfo
- Publication number
- ID24358A ID24358A IDW991188A ID991188A ID24358A ID 24358 A ID24358 A ID 24358A ID W991188 A IDW991188 A ID W991188A ID 991188 A ID991188 A ID 991188A ID 24358 A ID24358 A ID 24358A
- Authority
- ID
- Indonesia
- Prior art keywords
- prostatic
- propilactic
- benost
- treatment
- selective modulators
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4322397P | 1997-04-09 | 1997-04-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID24358A true ID24358A (id) | 2000-07-13 |
Family
ID=21926126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW991188A ID24358A (id) | 1997-04-09 | 1998-04-07 | Pengobatan atau propilaksis dari kanker prostatik dan hiperplasia prostatik benign dengan modulator selektif reseptor estrogen |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0975629A4 (no) |
| JP (1) | JP2001518900A (no) |
| KR (1) | KR20010006218A (no) |
| CN (1) | CN1259944A (no) |
| AU (1) | AU6966198A (no) |
| BR (1) | BR9808515A (no) |
| CA (1) | CA2286204A1 (no) |
| EA (1) | EA199900914A1 (no) |
| HU (1) | HUP0003589A3 (no) |
| ID (1) | ID24358A (no) |
| IL (1) | IL132277A0 (no) |
| NO (1) | NO994903L (no) |
| PL (1) | PL336205A1 (no) |
| TR (1) | TR199902701T2 (no) |
| WO (1) | WO1998045288A1 (no) |
| ZA (1) | ZA982819B (no) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6413533B1 (en) * | 1998-05-07 | 2002-07-02 | The University Of Tennessee Research Corporation | Method for chemoprevention of prostate cancer |
| US6610706B1 (en) | 1999-07-29 | 2003-08-26 | Eli Lilly And Company | Crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride |
| US6653479B1 (en) | 1999-07-29 | 2003-11-25 | Eli Lilly And Company | Crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b] thiophene hydrochloride |
| US7425565B2 (en) * | 2002-05-09 | 2008-09-16 | Cedars-Sinai Medical Center | Use of benzothiopenes to treat and prevent prostate cancer |
| US20020198235A1 (en) * | 2001-05-10 | 2002-12-26 | Cedars-Sinai Medical Center | Use of benzothiopenes to treat and prevent prostate cancer |
| MX2008014825A (es) * | 2006-05-22 | 2008-12-01 | Hormos Medical Ltd | Moduladores selectivos del receptor de estrogeno o inhibidores de aromatasa para tratar prostatitis cronica no bacteriana. |
| ME00996B (me) | 2007-10-16 | 2012-10-20 | Repros Therapeutics Inc | Trans-klomifen za liječenje metaboličkog sindroma |
| US20150031656A1 (en) | 2012-02-29 | 2015-01-29 | Repros Therapeutics Inc. | Combination therapy for treating androgen deficiency |
| SG11201505697VA (en) | 2013-02-19 | 2015-09-29 | Novartis Ag | Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders |
| US11633382B2 (en) | 2015-11-10 | 2023-04-25 | Paracrine Therapeutics Ab | Treatment of ER-negative breast cancer with an PDGF-CC inhibitor and anti-estrogen |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5429922A (en) * | 1988-03-09 | 1995-07-04 | The Board Of Trustees Of The Leland Stanford Junior University | Composition and method for distinguishing virulent and non-virulent toxoplasma infections |
| PL182493B1 (pl) * | 1995-02-28 | 2002-01-31 | Lilly Co Eli | Nowe pochodne benzotiofenu, nowe związki pośrednie i sposób wytwarzania nowych pochodnych benzotiofenu oraz środek farmaceutyczny |
| US5510357A (en) * | 1995-02-28 | 1996-04-23 | Eli Lilly And Company | Benzothiophene compounds as anti-estrogenic agents |
| US5731342A (en) * | 1996-02-22 | 1998-03-24 | Eli Lilly And Company | Benzothiophenes, formulations containing same, and methods |
-
1998
- 1998-04-02 ZA ZA9802819A patent/ZA982819B/xx unknown
- 1998-04-07 AU AU69661/98A patent/AU6966198A/en not_active Abandoned
- 1998-04-07 BR BR9808515-8A patent/BR9808515A/pt not_active Application Discontinuation
- 1998-04-07 EP EP98915488A patent/EP0975629A4/en not_active Withdrawn
- 1998-04-07 ID IDW991188A patent/ID24358A/id unknown
- 1998-04-07 WO PCT/US1998/007274 patent/WO1998045288A1/en not_active Application Discontinuation
- 1998-04-07 HU HU0003589A patent/HUP0003589A3/hu unknown
- 1998-04-07 IL IL13227798A patent/IL132277A0/xx unknown
- 1998-04-07 PL PL98336205A patent/PL336205A1/xx unknown
- 1998-04-07 TR TR1999/02701T patent/TR199902701T2/xx unknown
- 1998-04-07 CN CN98805956A patent/CN1259944A/zh active Pending
- 1998-04-07 KR KR1019997009298A patent/KR20010006218A/ko not_active Application Discontinuation
- 1998-04-07 EA EA199900914A patent/EA199900914A1/ru unknown
- 1998-04-07 CA CA002286204A patent/CA2286204A1/en not_active Abandoned
- 1998-04-07 JP JP54316898A patent/JP2001518900A/ja active Pending
-
1999
- 1999-10-08 NO NO994903A patent/NO994903L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO994903L (no) | 1999-12-09 |
| ZA982819B (en) | 1999-10-04 |
| EP0975629A4 (en) | 2001-03-21 |
| TR199902701T2 (xx) | 2000-02-21 |
| BR9808515A (pt) | 2001-06-19 |
| WO1998045288A1 (en) | 1998-10-15 |
| EA199900914A1 (ru) | 2000-04-24 |
| IL132277A0 (en) | 2001-03-19 |
| EP0975629A1 (en) | 2000-02-02 |
| PL336205A1 (en) | 2000-06-05 |
| AU6966198A (en) | 1998-10-30 |
| NO994903D0 (no) | 1999-10-08 |
| CN1259944A (zh) | 2000-07-12 |
| HUP0003589A2 (hu) | 2002-01-28 |
| CA2286204A1 (en) | 1998-10-15 |
| KR20010006218A (ko) | 2001-01-26 |
| JP2001518900A (ja) | 2001-10-16 |
| HUP0003589A3 (en) | 2002-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60023982D1 (de) | System zur Behandlung von benigner Prostatahyperplasie | |
| DE69927084D1 (de) | Sigma-delta Modulator und Modulationsverfahren | |
| DK0925069T3 (da) | Anvendelse af Cetrorelix til behandling af godartet prostatahypertrofi og prostatacancer | |
| NO993396L (no) | Kinolin- og kinolinforbindelser nyttige i terapi, spesielt i behandlingen av benign prostatisk hyperplasi | |
| ID27614A (id) | Metode dan radas untuk terapi gelombang | |
| ID19746A (id) | Aparatus dan metoda masukan dan kendali multimedia untuk komunikasi multimedia | |
| DE69832657D1 (de) | Empfangseinrichtungen und Empfangsverfahren | |
| DE69835254D1 (de) | Empfangseinrichtungen und Empfangsverfahren | |
| EE9900415A (et) | IQ-modulaator ja sellega seotud meetod | |
| ID27986A (id) | Pengobatan terhadap gangguan sistem syaraf pusat dengan modulator reseptor estrogen selektif | |
| EP0909067A4 (en) | MODULATOR AND MODULATION PROCESS | |
| AU1316000A (en) | Compositions and methods for treating benign prostatic hyperplasia using tocotrienols | |
| ID24358A (id) | Pengobatan atau propilaksis dari kanker prostatik dan hiperplasia prostatik benign dengan modulator selektif reseptor estrogen | |
| NO20011162L (no) | Fremgangsmåter og preparater for modulering av interaksjonen mellom APJ-reseptoren og HIV-viruset | |
| DE69830435D1 (de) | Räumlischer LichtModulator und Anzeige | |
| ID23159A (id) | Wafer dan pembuatannya | |
| ID26873A (id) | Kombinasi terapeutik yang terdiri dari modulator reseptor estrogen selektif dan hormon paratiroid | |
| ID23163A (id) | Turunan-turunan piridina dan komposisi-komposisi farmasi yang mengandungnya | |
| AU9128998A (en) | Composition and method for the treatment of benign prostatic hyperplasia and prostatitis | |
| ID23653A (id) | Pencegahan kanker payudara dengan modulator reseptor estrogen selektif | |
| DE69831626D1 (de) | Datenmodulation und -übertragung | |
| ID18913A (id) | Turunan turunan tienopiridin dan penggunaannya | |
| ID22345A (id) | Penghilangan 6-aminokapronitril dari campuran-campuran yang terdiri dari 6-aminokapronitril dan suatu imina | |
| AU6570998A (en) | Prostate specific antigen from benign prostatic hyperplasia and its use in diagnosis | |
| IL122316A0 (en) | Melatonin agonists for treating benign prostatic hyperplasia |